MoneyWorks4Me

Transgene Biotek - Quaterly Results

07 Aug 2025 Evaluate
The total revenue for the quarter ended June 2025 remained nearly unchanged at Rs. 0.50 millions.The Net Loss for the quarter ended June 2025 is Rs. -4.34 millions as compared to Net Profit of Rs. 2.00 millions of corresponding quarter ended June 2024Operating profit Margin for the quarter ended June 2025 slipped to -1.38% as compared to 2.40% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.50 0.49 2.04 0.50 0.49 2.04 2.61 2.35 11.06
Other Income 0.00 6.52 0.00 0.00 6.52 0.00 7.84 1.83 328.42
PBIDT -1.38 2.40 -157.50 -1.38 2.40 -157.50 -3.40 -4.34 -21.66
Interest 2.46 0.17 1347.06 2.46 0.17 1347.06 2.43 1.29 88.37
PBDT -3.84 2.23 -272.20 -3.84 2.23 -272.20 -5.83 -5.63 3.55
Depreciation 0.50 0.23 117.39 0.50 0.23 117.39 0.93 0.92 1.09
PBT -4.34 2.00 -317.00 -4.34 2.00 -317.00 -6.76 -6.55 3.21
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -4.34 2.00 -317.00 -4.34 2.00 -317.00 -6.76 -6.55 3.21
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) -276.00 489.80 -156.35 -276.00 489.80 -156.35 -130.27 -184.68 -29.46
Peers
Company Name CMP
Sagility 45.15
Knowledge RealtyTrt. 113.28
Prime Focus 310.60
Indegene 578.05
Syngene Internatl. 382.65
View more..